Dec. 8, 2011
-- Continuing its growth path, Genadyne Biotechnologies expands its services and products into the Latin American market. A new office headquartered in Mexico City is the gateway to bring Genadyne's suite of specialty mattresses, and its Advanced Negative Pressure Wound Therapy the XLR8 to help reduce and treat wound occurrence.
“This year has shown unprecedented growth for us as a company. As with all our other territories I feel it necessary to have a grassroots presence. They continue to make advances in our technology, and it is a great pleasure to be able to provide to Mexico and Latin America.It has been a very exciting year for us and we are looking forward to what 2012 has to offer.” Says Shahzad Pirzada, President of Genadyne Biotechnologies.
Shahzad has 14 years of experience developing and bring to the market a wide array of respiratory products -- primarily CPAP and BIPAP technologies and portable oxygen delivering systems. Shahzad is a founder of Genadyne Biotechnologies, Inc., an international company with distributors across North America and Europe. He holds 11 patents - and - multiple-pending on air flotation surfaces, non-powered air surfaces, wireless weight scale systems and blood circulation devices. Shahzad is a pilot by training, with a background in avionics and aeronautical engineering from The College of Aeronautics in New York.
Genadyne Biotechnologies Inc. is a US based developer and manufacturer of negative pressure wound therapy systems, non-powered and powered pressure relieving therapeutic surfaces, wireless telemedicine solutions, wireless and wired weight scale systems and more. The mission of Genadyne is to promote wound healing, decrease wound recurrence and maintain the dignity, independence, comfort and pain control of the wound care patient through our products and through education.